ATAGI update following weekly COVID-19 meeting – 11 May 2022

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 11 May 2022.

Date published:
General public

Latest recommendation updates

ATAGI have not published any updated advice or recommendations since 29 April 2022.

Recent ATAGI considerations

On Wednesday 11 May 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. As of 10 May 2022, over 58 million doses of COVID-19 vaccines have been administered in Australia.

ATAGI considered data on Omicron vaccine effectiveness in New South Wales and continued to examine evidence relating to need for 4th (winter) doses of COVID-19 vaccine for at risk groups, including individuals with disability and individuals with medical comorbidities.

Ongoing review of adverse events and safety information

The TGA Weekly Report provides a detailed breakdown of adverse events following immunisation, including Australian rates of myocarditis and pericarditis.

Resources and recent statements

More information can be found in the following resources:

More information can be found on the Department of Health website, with resources for both providers and patients.

Help us improve

If you would like a response please use the enquiries form instead.